Showing results (81-90 of 940) with videos related to

Sort By:
Pageof 94
Neurology and Therapy|April 15, 2023
Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE StudiesLilyana Amezcua, Yang Mao-Draayer, Wendy S Vargas, et al.
Neurology and Therapy|April 7, 2021
Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database AnalysisDarshan Mehta, Drishti Shah, Vibha Desai, et al.
Neurology and Therapy|August 9, 2020
Management of Migraine and the Accessibility of Specialist Care: Findings from an Extended Multinational Survey (My Migraine Center Survey)Siriporn Wongsiriroj, Elisabetta Grillo, Sabrina Levi, et al.
Neurology and Therapy|April 23, 2021
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab EmiratesJihad S Inshasi, Sarmed Alfahad, Taoufik Alsaadi, et al.
Neurology and Therapy|April 5, 2023
Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022Carla Abdelnour, Maria Camila Gonzalez, Lucy L Gibson, et al.
Neurology and Therapy|March 31, 2023
Cost Per Relapse Avoided for Ozanimod Versus Other Selected Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis in the United StatesDaniel Kantor, Timothy Pham, Oscar Patterson-Lomba, et al.
Neurology and Therapy|April 24, 2023
Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese SubjectsBeibei Liang, Jin Wang, Guanxuanzi Zhang, et al.
Neurology and Therapy|April 15, 2021
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache CentersElizabeth Faust, Irina Pivneva, Karen Yang, et al.
Neurology and Therapy|April 13, 2021
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and AdherenceJacob Liseno, Brittney Lager, Catherine Miller, et al.
Neurology and Therapy|September 1, 2022
Circulating Insulin-Like Growth Factor 1 Levels and Migraine Risk: A Mendelian Randomization StudyReziya Abuduxukuer, Peng-Peng Niu, Zhen-Ni Guo, et al.
Pageof 94